The whole point is to see if the gelatin itself makes a difference, and you can't tell if you're changing ten things at once
Per Omzo's Shipping Policy, if medication arrives damaged or there are product concerns, contact the support team to initiate an investigation with the pharmacy
Sources TripleHormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial | New England Journal of Medicine How to use the Mounjaro (tirzepatide) KwikPen Ozempic Pen Ozempic NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current
So far, however, it has been injectables leading the way to approval
So here are some takeaways on the longevity of the obesity platform: Even without GLP-1 craze they grew the business (profitably?) to a $100M run-rate in 7 months with oral weight loss medications alone We will see a flood of new GLP-1 medications enter the market and the situation will move quickly and be fluid including the introduction of oral compounds that may lead to other use-cases for Hims There is some sort of precedent that compounding certain elements like end-dosage or side effect mitigation is considered clinically necessary and therefore defensible Hims & Hers will also offer brand-name GLP-1s on platform, maybe alluding to expectations of reduction in out of pocket cost over time, or an increase in supply My unsolicited thoughts for Hims would be to take advantage of this huge surge in cash and invest it into the sustainable, growing parts of the business
